The company was founded in 2001 and listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange in 2021. It is an innovation-driven pharmaceutical manufacturer with multiple R&D centers and global innovation resources, covering the traditional Chinese medicine, chemical medicine, and biomacromolecule drug industry chain, based in China and with a global layout. The company's main business is R&D, production and sales of chemical preparations, chemical raw materials and traditional Chinese medicine preparations. The company's main products are pharmaceutical products, APIs, intermediates, pharmaceutical excipients and other products. Corporate honors: 2020 Independent Innovation Award, 2020 Tax Contribution Award, 2020 Intelligent Development Award, 2020 Scale Development Award, etc.